News | February 09, 2024
Spriya Lifescience Q3 FY24 PAT jumps 213% at Rs. 29.79 Cr
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The company intends to respond to the two minor observations within the stipulated time
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories
The company has secured two orders for male condoms from CMSS worth Rs. 9.65 crores and Rs. 6.58 crores respectively
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Subscribe To Our Newsletter & Stay Updated
